In 2017,Paunovic, Amalia I.; Drowley, Lauren; Nordqvist, Anneli; Ericson, Elke; Mouchet, Elizabeth; Jonebring, Anna; Groenberg, Gunnar; Kvist, Alexander J.; Engkvist, Ola; Brown, Martin R.; Gedda, Karin; Goumans, Marie-Jose; Wang, Qing-Dong; Plowright, Alleyn T. published 《Phenotypic Screen for Cardiac Regeneration Identifies Molecules with Differential Activity in Human Epicardium-Derived Cells versus Cardiac Fibroblasts》.ACS Chemical Biology published the findings.Related Products of 329-59-9 The information in the text is summarized as follows:
Activation and proliferation of resident cardiac progenitor cells has therapeutic potential to repair the heart after injury. However, research has been impeded by lack of well-defined and characterized cell sources and difficulties in translation to screening platforms. Here the authors describe the development, validation, and use of a 384 well phenotypic assay in primary human epicardium-derived cells (EPDCs) to identify compounds that induce proliferation while maintaining the progenitor phenotype. Using this assay, the authors have screened 7400 structurally diverse compounds where >90% are biol. annotated and known to modulate a broad range of biol. targets. From the primary screen, the authors identified and validated hits and expanded upon the lead mols. of interest. A counter screen was developed in human primary cardiac fibroblasts to filter out compounds with a general proliferative effect, after which the activity of selected mols. was confirmed across multiple EPDC donors. To further examine the mechanism of action of compounds with annotated targets, the authors performed knockdown experiments to understand whether a single known target was responsible for the proliferative effect, confirming results with protein expression and activity assays. Here the authors were able to show that the annotated targets of compounds of interest were not responsible for the proliferative effect, which highlights potential differences in cell types and signaling pathways and possible polypharmacol. These studies demonstrate the feasibility of using relevant human primary cells in a phenotypic screen to identify compounds as novel biol. tools and starting points for drug discovery projects and the authors disclose the first small mols. to proliferate human primary EPDCs. In the experimental materials used by the author, we found Methyl 4-fluoro-3-nitrobenzoate(cas: 329-59-9Related Products of 329-59-9)
Methyl 4-fluoro-3-nitrobenzoate(cas: 329-59-9) belongs to methyl benzoate. Methyl benzoate reacts at both the ring and the ester, depending on the substrate. Electrophiles attack the ring, illustrated by acid-catalysed nitration with nitric acid to give methyl 3-nitrobenzoate.Related Products of 329-59-9
Referemce:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics